Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerance of subcutaneous injections of natural interferon alpha
(IFN) in asymptomatic HIV-positive persons and record its effects on the HIV virus in these
individuals.
Phase:
Phase 1
Details
Lead Sponsor:
Purdue Frederick
Collaborators:
Henry M. Jackson Foundation for the Advancement of Military Medicine Walter Reed Army Institute of Research (WRAIR)